| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,545 | 1,537 | 1,402 | 1,406 | 1,384 | 1,425 | 1,506 | 1,487 | 1,695 | 1,743 | 1,800 | 1,834 | |
Growth YoY Revenue Growth YoY% | 64.7 | 95.8 | 16.0 | 2.4 | -10.4 | -7.3 | 7.4 | 5.8 | 22.5 | 22.3 | 19.6 | 23.3 |
| 1,189 | 1,179 | 1,137 | 1,109 | 1,024 | 1,077 | 1,138 | 1,173 | 1,260 | 1,230 | 1,311 | 1,350 | |
| 356 | 359 | 264 | 297 | 360 | 348 | 368 | 314 | 435 | 513 | 489 | 484 | |
OPM OPM% | 23.1 | 23.3 | 18.9 | 21.1 | 26.0 | 24.4 | 24.4 | 21.1 | 25.6 | 29.4 | 27.2 | 26.4 |
| 37 | 42 | 51 | 60 | 58 | 44 | 58 | 84 | 39 | 111 | 61 | 69 | |
Interest Expense Interest ExpenseCr | 5 | 10 | 6 | 6 | 23 | 7 | 12 | 8 | 4 | 10 | 4 | 7 |
Depreciation DepreciationCr | 105 | 93 | 92 | 94 | 96 | 96 | 101 | 106 | 108 | 109 | 111 | 115 |
PBT PBTCr | 283 | 298 | 218 | 257 | 299 | 288 | 313 | 284 | 362 | 506 | 435 | 431 |
| 91 | 106 | 74 | 93 | 95 | 102 | 97 | 100 | 101 | 139 | 118 | 140 | |
| 192 | 192 | 144 | 164 | 205 | 187 | 215 | 184 | 261 | 367 | 317 | 291 | |
Growth YoY PAT Growth YoY% | -17.3 | 144.6 | -25.9 | -15.7 | 6.7 | -3.1 | 49.9 | 12.3 | 27.7 | 96.6 | 47.1 | 58.3 |
NPM NPM% | 12.4 | 12.5 | 10.3 | 11.6 | 14.8 | 13.1 | 14.3 | 12.3 | 15.4 | 21.0 | 17.6 | 15.9 |
| 11.7 | 11.7 | 8.7 | 9.9 | 12.4 | 11.3 | 13.1 | 11.2 | 15.9 | 22.3 | 19.2 | 17.6 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,545 | 1,537 | 1,402 | 1,406 | 1,384 | 1,425 | 1,506 | 1,487 | 1,695 | 1,743 | 1,800 | 1,834 | |
Growth YoY Revenue Growth YoY% | 64.7 | 95.8 | 16.0 | 2.4 | -10.4 | -7.3 | 7.4 | 5.8 | 22.5 | 22.3 | 19.6 | 23.3 |
| 1,189 | 1,179 | 1,137 | 1,109 | 1,024 | 1,077 | 1,138 | 1,173 | 1,260 | 1,230 | 1,311 | 1,350 | |
| 356 | 359 | 264 | 297 | 360 | 348 | 368 | 314 | 435 | 513 | 489 | 484 | |
OPM OPM% | 23.1 | 23.3 | 18.9 | 21.1 | 26.0 | 24.4 | 24.4 | 21.1 | 25.6 | 29.4 | 27.2 | 26.4 |
| 37 | 42 | 51 | 60 | 58 | 44 | 58 | 84 | 39 | 111 | 61 | 69 | |
Interest Expense Interest ExpenseCr | 5 | 10 | 6 | 6 | 23 | 7 | 12 | 8 | 4 | 10 | 4 | 7 |
Depreciation DepreciationCr | 105 | 93 | 92 | 94 | 96 | 96 | 101 | 106 | 108 | 109 | 111 | 115 |
PBT PBTCr | 283 | 298 | 218 | 257 | 299 | 288 | 313 | 284 | 362 | 506 | 435 | 431 |
| 91 | 106 | 74 | 93 | 95 | 102 | 97 | 100 | 101 | 139 | 118 | 140 | |
| 192 | 192 | 144 | 164 | 205 | 187 | 215 | 184 | 261 | 367 | 317 | 291 | |
Growth YoY PAT Growth YoY% | -17.3 | 144.6 | -25.9 | -15.7 | 6.7 | -3.1 | 49.9 | 12.3 | 27.7 | 96.6 | 47.1 | 58.3 |
NPM NPM% | 12.4 | 12.5 | 10.3 | 11.6 | 14.8 | 13.1 | 14.3 | 12.3 | 15.4 | 21.0 | 17.6 | 15.9 |
| 11.7 | 11.7 | 8.7 | 9.9 | 12.4 | 11.3 | 13.1 | 11.2 | 15.9 | 22.3 | 19.2 | 17.6 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 2,633 | 3,463 | 4,401 | 3,625 | 5,665 | 5,617 | 6,431 | 7,072 |
Growth Revenue Growth% | 31.5 | 27.1 | -17.6 | 56.3 | -0.8 | 14.5 | 21.9 | |
| 1,678 | 2,161 | 2,891 | 2,600 | 4,332 | 4,348 | 4,801 | 5,151 | |
| 955 | 1,302 | 1,510 | 1,025 | 1,333 | 1,269 | 1,630 | 1,921 | |
OPM OPM% | 36.3 | 37.6 | 34.3 | 28.3 | 23.5 | 22.6 | 25.3 | 27.2 |
| 139 | 135 | 224 | 184 | 170 | 214 | 292 | 281 | |
Interest Expense Interest ExpenseCr | 7 | 3 | 5 | 7 | 26 | 42 | 33 | 25 |
Depreciation DepreciationCr | 95 | 99 | 110 | 147 | 345 | 378 | 424 | 443 |
PBT PBTCr | 993 | 1,335 | 1,619 | 1,055 | 1,133 | 1,063 | 1,465 | 1,734 |
| 220 | 338 | 407 | 274 | 360 | 364 | 437 | 498 | |
PAT PATCr | 773 | 997 | 1,212 | 781 | 772 | 699 | 1,027 | 1,236 |
Growth PAT Growth% | 29.0 | 21.5 | -35.5 | -1.1 | -9.6 | 47.1 | 56.4 | |
NPM NPM% | 29.4 | 28.8 | 27.5 | 21.6 | 13.6 | 12.4 | 16.0 | 17.5 |
| 49.9 | 63.1 | 73.8 | 47.4 | 46.9 | 42.4 | 62.4 | 75.0 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 2,633 | 3,463 | 4,401 | 3,625 | 5,665 | 5,617 | 6,431 | 7,072 |
Growth Revenue Growth% | 31.5 | 27.1 | -17.6 | 56.3 | -0.8 | 14.5 | 21.9 | |
| 1,678 | 2,161 | 2,891 | 2,600 | 4,332 | 4,348 | 4,801 | 5,151 | |
| 955 | 1,302 | 1,510 | 1,025 | 1,333 | 1,269 | 1,630 | 1,921 | |
OPM OPM% | 36.3 | 37.6 | 34.3 | 28.3 | 23.5 | 22.6 | 25.3 | 27.2 |
| 139 | 135 | 224 | 184 | 170 | 214 | 292 | 281 | |
Interest Expense Interest ExpenseCr | 7 | 3 | 5 | 7 | 26 | 42 | 33 | 25 |
Depreciation DepreciationCr | 95 | 99 | 110 | 147 | 345 | 378 | 424 | 443 |
PBT PBTCr | 993 | 1,335 | 1,619 | 1,055 | 1,133 | 1,063 | 1,465 | 1,734 |
| 220 | 338 | 407 | 274 | 360 | 364 | 437 | 498 | |
PAT PATCr | 773 | 997 | 1,212 | 781 | 772 | 699 | 1,027 | 1,236 |
Growth PAT Growth% | 29.0 | 21.5 | -35.5 | -1.1 | -9.6 | 47.1 | 56.4 | |
NPM NPM% | 29.4 | 28.8 | 27.5 | 21.6 | 13.6 | 12.4 | 16.0 | 17.5 |
| 49.9 | 63.1 | 73.8 | 47.4 | 46.9 | 42.4 | 62.4 | 75.0 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 |
Reserves ReservesCr | 3,631 | 5,887 | 7,141 | 7,942 | 8,707 | 9,134 | 10,341 | 10,669 |
| 359 | 513 | 582 | 729 | 1,398 | 1,565 | 1,608 | 1,714 | |
| 81 | 80 | 94 | 90 | 539 | 509 | 545 | 527 | |
| 4,086 | 6,496 | 7,834 | 8,778 | 10,661 | 11,225 | 12,511 | 12,927 | |
| 2,846 | 5,124 | 5,852 | 6,901 | 5,645 | 6,783 | 7,527 | 7,872 | |
| 1,240 | 1,372 | 1,982 | 1,877 | 5,016 | 4,442 | 4,984 | 5,054 | |
| 4,086 | 6,496 | 7,834 | 8,778 | 10,661 | 11,225 | 12,511 | 12,927 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 |
Reserves ReservesCr | 3,631 | 5,887 | 7,141 | 7,942 | 8,707 | 9,134 | 10,341 | 10,669 |
| 359 | 513 | 582 | 729 | 1,398 | 1,565 | 1,608 | 1,714 | |
| 81 | 80 | 94 | 90 | 539 | 509 | 545 | 527 | |
| 4,086 | 6,496 | 7,834 | 8,778 | 10,661 | 11,225 | 12,511 | 12,927 | |
| 2,846 | 5,124 | 5,852 | 6,901 | 5,645 | 6,783 | 7,527 | 7,872 | |
| 1,240 | 1,372 | 1,982 | 1,877 | 5,016 | 4,442 | 4,984 | 5,054 | |
| 4,086 | 6,496 | 7,834 | 8,778 | 10,661 | 11,225 | 12,511 | 12,927 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 701 | 605 | 791 | 364 | 997 | 915 | 1,031 | |
| -766 | -1,524 | -1,003 | 1,208 | -1,757 | 1,705 | 138 | |
| -7 | 1,238 | 35 | 15 | -799 | -433 | -417 | |
Net Cash Flow Net Cash FlowCr | -72 | 319 | -177 | 1,587 | -1,560 | 2,186 | 752 |
Free Cash Flow Free Cash FlowCr | 530 | 377 | 280 | 143 | 608 | 531 | 541 |
CFO To PAT CFO To PAT% | 90.7 | 60.7 | 65.3 | 46.6 | 129.0 | 130.9 | 100.4 |
CFO To EBITDA CFO To EBITDA% | 73.4 | 46.5 | 52.4 | 35.5 | 74.8 | 72.1 | 63.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 701 | 605 | 791 | 364 | 997 | 915 | 1,031 | |
| -766 | -1,524 | -1,003 | 1,208 | -1,757 | 1,705 | 138 | |
| -7 | 1,238 | 35 | 15 | -799 | -433 | -417 | |
Net Cash Flow Net Cash FlowCr | -72 | 319 | -177 | 1,587 | -1,560 | 2,186 | 752 |
Free Cash Flow Free Cash FlowCr | 530 | 377 | 280 | 143 | 608 | 531 | 541 |
CFO To PAT CFO To PAT% | 90.7 | 60.7 | 65.3 | 46.6 | 129.0 | 130.9 | 100.4 |
CFO To EBITDA CFO To EBITDA% | 73.4 | 46.5 | 52.4 | 35.5 | 74.8 | 72.1 | 63.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 40,535 | 53,713 | 20,894 | 30,338 | 26,233 | 27,964 | 54,981 | |
Price To Earnings Price To Earnings | 40.7 | 44.3 | 26.8 | 39.3 | 37.5 | 27.2 | 44.4 | |
Price To Sales Price To Sales | 11.7 | 12.2 | 5.8 | 5.4 | 4.7 | 4.3 | 7.8 | |
Price To Book Price To Book | 6.9 | 7.5 | 2.6 | 3.5 | 2.9 | 2.7 | 5.2 | |
EV To EBITDA EV To EBITDA | 28.8 | 33.5 | 16.7 | 21.7 | 18.9 | 15.3 | 27.0 | |
GPM GPM% | 51.3 | 51.0 | 46.8 | 45.8 | 52.4 | 53.6 | 56.5 | 56.5 |
OPM OPM% | 36.3 | 37.6 | 34.3 | 28.3 | 23.5 | 22.6 | 25.3 | 27.2 |
NPM NPM% | 29.4 | 28.8 | 27.5 | 21.6 | 13.6 | 12.4 | 16.0 | 17.5 |
ROCE ROCE% | 27.4 | 22.6 | 22.7 | 13.3 | 12.7 | 11.7 | 14.1 | 16.1 |
ROE ROE% | 21.2 | 16.9 | 16.9 | 9.8 | 8.8 | 7.6 | 9.9 | 11.6 |
ROA ROA% | 18.9 | 15.3 | 15.5 | 8.9 | 7.3 | 6.2 | 8.2 | 9.6 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 40,535 | 53,713 | 20,894 | 30,338 | 26,233 | 27,964 | 54,981 | |
Price To Earnings Price To Earnings | 40.7 | 44.3 | 26.8 | 39.3 | 37.5 | 27.2 | 44.4 | |
Price To Sales Price To Sales | 11.7 | 12.2 | 5.8 | 5.4 | 4.7 | 4.3 | 7.8 | |
Price To Book Price To Book | 6.9 | 7.5 | 2.6 | 3.5 | 2.9 | 2.7 | 5.2 | |
EV To EBITDA EV To EBITDA | 28.8 | 33.5 | 16.7 | 21.7 | 18.9 | 15.3 | 27.0 | |
GPM GPM% | 51.3 | 51.0 | 46.8 | 45.8 | 52.4 | 53.6 | 56.5 | 56.5 |
OPM OPM% | 36.3 | 37.6 | 34.3 | 28.3 | 23.5 | 22.6 | 25.3 | 27.2 |
NPM NPM% | 29.4 | 28.8 | 27.5 | 21.6 | 13.6 | 12.4 | 16.0 | 17.5 |
ROCE ROCE% | 27.4 | 22.6 | 22.7 | 13.3 | 12.7 | 11.7 | 14.1 | 16.1 |
ROE ROE% | 21.2 | 16.9 | 16.9 | 9.8 | 8.8 | 7.6 | 9.9 | 11.6 |
ROA ROA% | 18.9 | 15.3 | 15.5 | 8.9 | 7.3 | 6.2 | 8.2 | 9.6 |
| Market CapitalizationMkt CapCr | 74,733 | 61,994 | 59,386 | 54,981 | 46,778 | 44,351 | 41,458 |
| Close PriceClose₹ | 2,648.00 | 5,185.00 | 364.40 | 3,331.90 | 1,843.80 | 2,337.80 | 3,317.70 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 51.49 | 29.98 | 121.87 | 44.44 | 32.46 | 40.54 | 32.82 |
| Price To SalesPS | 4.69 | 3.97 | 3.41 | 7.77 | 4.46 | 4.33 | 6.67 |
| RevenueRevenueCr | 15,937 | 15,632 | 17,415 | 7,072 | 10,479 | 10,234 | 6,217 |
| Revenue Growth TTMRev Gr TTM% | -0.1% | 12.5% | 5.7% | 21.9% | 12.0% | 21.1% | 25.0% |
| PAT Growth TTMPAT Gr TTM% | 43.7% | -13.2% | -55.4% | 56.4% | 72.8% | 33.3% | 29.7% |
| Market CapitalizationMkt CapCr | 74,733 | 61,994 | 59,386 | 54,981 | 46,778 | 44,351 | 41,458 |
| Close PriceClose₹ | 2,648.00 | 5,185.00 | 364.40 | 3,331.90 | 1,843.80 | 2,337.80 | 3,317.70 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 51.49 | 29.98 | 121.87 | 44.44 | 32.46 | 40.54 | 32.82 |
| Price To SalesPS | 4.69 | 3.97 | 3.41 | 7.77 | 4.46 | 4.33 | 6.67 |
| RevenueRevenueCr | 15,937 | 15,632 | 17,415 | 7,072 | 10,479 | 10,234 | 6,217 |
| Revenue Growth TTMRev Gr TTM% | -0.1% | 12.5% | 5.7% | 21.9% | 12.0% | 21.1% | 25.0% |
| PAT Growth TTMPAT Gr TTM% | 43.7% | -13.2% | -55.4% | 56.4% | 72.8% | 33.3% | 29.7% |